KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Income from Continuing Operations (2016 - 2026)

Bristol Myers Squibb has reported Income from Continuing Operations over the past 18 years, most recently at 2679000000.0 for Q1 2026.

  • Quarterly Income from Continuing Operations rose 8.81% to 2679000000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 7273000000.0 through Mar 2026, up 33.77% year-over-year, with the annual reading at 7056000000.0 for FY2025, 178.99% up from the prior year.
  • Income from Continuing Operations was 2679000000.0 for Q1 2026 at Bristol Myers Squibb, up from 1086000000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 2679000000.0 in Q1 2026 and troughed at 11908000000.0 in Q1 2024.
  • The 5-year median for Income from Continuing Operations is 1684000000.0 (2024), against an average of 893352941.18.
  • Year-over-year, Income from Continuing Operations plummeted 625.28% in 2024 and then soared 1328.95% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 2025000000.0 in 2022, then dropped by 12.99% to 1762000000.0 in 2023, then crashed by 95.69% to 76000000.0 in 2024, then soared by 1328.95% to 1086000000.0 in 2025, then soared by 146.69% to 2679000000.0 in 2026.
  • Per Business Quant, the three most recent readings for BMY's Income from Continuing Operations are 2679000000.0 (Q1 2026), 1086000000.0 (Q4 2025), and 2195000000.0 (Q3 2025).